These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1288 related articles for article (PubMed ID: 34363945)
41. Optimisation and evaluation of viral genomic sequencing of SARS-CoV-2 rapid diagnostic tests: a laboratory and cohort-based study. Paull JS; Petros BA; Brock-Fisher TM; Jalbert SA; Selser VM; Messer KS; Dobbins ST; DeRuff KC; Deng D; Springer M; Sabeti PC Lancet Microbe; 2024 May; 5(5):e468-e477. PubMed ID: 38621394 [TBL] [Abstract][Full Text] [Related]
42. Rapid screening of SARS-CoV-2 infection: Good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals. Sicilia P; Castro G; Fantilli AC; Gierotto R; López L; Barbás MG; Pisano MB; Ré VE PLoS One; 2022; 17(4):e0266375. PubMed ID: 35363814 [TBL] [Abstract][Full Text] [Related]
43. Comparison of the SARS-CoV-2 BD Veritor Nasal Antigen Test with Nasopharyngeal Reverse Transcription-PCR in Symptomatic Patients. Koga P; Maluf M; Nunes F; Campos J; Gazarini L; Borghoff T; Libanori G; Martino M Microbiol Spectr; 2022 Oct; 10(5):e0019022. PubMed ID: 36036635 [TBL] [Abstract][Full Text] [Related]
44. Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center. Ashagre W; Atnafu A; Wassie L; Tschopp R; Fentahun D; Assefa G; Wegayehu T; Wondale B; Mulu A; Miheret A; Bobosha K PLoS One; 2022; 17(11):e0277779. PubMed ID: 36413550 [TBL] [Abstract][Full Text] [Related]
45. Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020. Pray IW; Ford L; Cole D; Lee C; Bigouette JP; Abedi GR; Bushman D; Delahoy MJ; Currie D; Cherney B; Kirby M; Fajardo G; Caudill M; Langolf K; Kahrs J; Kelly P; Pitts C; Lim A; Aulik N; Tamin A; Harcourt JL; Queen K; Zhang J; Whitaker B; Browne H; Medrzycki M; Shewmaker P; Folster J; Bankamp B; Bowen MD; Thornburg NJ; Goffard K; Limbago B; Bateman A; Tate JE; Gieryn D; Kirking HL; Westergaard R; Killerby M; MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1642-1647. PubMed ID: 33382679 [TBL] [Abstract][Full Text] [Related]
46. Comparison of the SARS-CoV-2 Rapid antigen test to the real star Sars-CoV-2 RT PCR kit. Krüttgen A; Cornelissen CG; Dreher M; Hornef MW; Imöhl M; Kleines M J Virol Methods; 2021 Feb; 288():114024. PubMed ID: 33227341 [TBL] [Abstract][Full Text] [Related]
48. Diagnostic Performance of Six Rapid Antigen Tests for SARS-CoV-2. Navero-Castillejos J; Casals-Pascual C; Narváez S; Cuesta G; Hurtado JC; Fernandez M; Navarro M; Peiró-Mestres A; Lasheras MV; Rodriguez P; Pulgarín A; Marcos MÁ; Vila J; Martínez MJ Microbiol Spectr; 2022 Apr; 10(2):e0235121. PubMed ID: 35293799 [TBL] [Abstract][Full Text] [Related]
49. Evaluation of the Roche antigen rapid test and a cell culture-based assay compared to rRT- PCR for the detection of SARS-CoV-2: A contribution to the discussion about SARS-CoV-2 diagnostic tests and contagiousness. Steinlin-Schopfer J; Barbani MT; Kamgang R; Zwahlen M; Suter-Riniker F; Dijkman R J Clin Virol Plus; 2021 Jun; 1(1):100020. PubMed ID: 35262007 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the Panbio COVID-19 Antigen Rapid Diagnostic Test in Subjects Infected with Omicron Using Different Specimens. Galliez RM; Bomfim L; Mariani D; Leitão IC; Castiñeiras ACP; Gonçalves CCA; Ortiz da Silva B; Cardoso PH; Arruda MB; Alvarez P; Brindeiro R; Ota VA; Rodrigues DGM; da Costa LJ; Ferreira ODC; Castiñeiras TMPP; Faffe DS; Tanuri A Microbiol Spectr; 2022 Jun; 10(3):e0125022. PubMed ID: 35652635 [TBL] [Abstract][Full Text] [Related]
51. Diagnostic Performance of Self-Collected Saliva Versus Nasopharyngeal Swab for the Molecular Detection of SARS-CoV-2 in the Clinical Setting. Uddin MKM; Shirin T; Hossain ME; Alam AN; Ami JQ; Hasan R; Miah M; Shaly NJ; Ahmed S; Rahman SMM; Rahman M; Banu S Microbiol Spectr; 2021 Dec; 9(3):e0046821. PubMed ID: 34730436 [TBL] [Abstract][Full Text] [Related]
52. Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 Contacts. Robinson ML; Mirza A; Gallagher N; Boudreau A; Garcia Jacinto L; Yu T; Norton J; Luo CH; Conte A; Zhou R; Kafka K; Hardick J; McManus DD; Gibson LL; Pekosz A; Mostafa HH; Manabe YC J Clin Microbiol; 2022 Jul; 60(7):e0018722. PubMed ID: 35730949 [TBL] [Abstract][Full Text] [Related]
53. Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs. Landaverde L; Turcinovic J; Doucette-Stamm L; Gonzales K; Platt J; Connor JH; Klapperich C Microbiol Spectr; 2022 Dec; 10(6):e0130722. PubMed ID: 36255297 [TBL] [Abstract][Full Text] [Related]
54. Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation. Irungu JK; Munyua P; Ochieng C; Juma B; Amoth P; Kuria F; Kiiru J; Makayotto L; Abade A; Bulterys M; Hunsperger E; Emukule GO; Onyango C; Samandari T; Barr BAT; Akelo V; Weyenga H; Munywoki PK; Bigogo G; Otieno NA; Kisivuli JA; Ochieng E; Nyaga R; Hull N; Herman-Roloff A; Aman R PLoS One; 2023; 18(1):e0277657. PubMed ID: 36696882 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2. Krüger LJ; Klein JAF; Tobian F; Gaeddert M; Lainati F; Klemm S; Schnitzler P; Bartenschlager R; Cerikan B; Neufeldt CJ; Nikolai O; Lindner AK; Mockenhaupt FP; Seybold J; Jones TC; Corman VM; Pollock NR; Knorr B; Welker A; de Vos M; Sacks JA; Denkinger CM; Infection; 2022 Apr; 50(2):395-406. PubMed ID: 34383260 [TBL] [Abstract][Full Text] [Related]
56. Performance of the Sofia SARS-CoV-2 rapid antigen test as frontline test in a university hospital, Germany. Bornemann L; Dähne T; Fomenko A; Kaup O; Kleideiter J; Kulis-Horn R; Ruprecht B; Wehmeier M; Panning M Diagn Microbiol Infect Dis; 2022 May; 103(1):115663. PubMed ID: 35331603 [TBL] [Abstract][Full Text] [Related]
57. Comparison of SARS-CoV-2 antigen electrochemiluminescence immunoassay to RT-PCR assay for laboratory diagnosis of COVID-19 in Peshawar. Iqbal B; Khan M; Shah N; Dawood MM; Jehanzeb V; Shafi M Diagnosis (Berl); 2022 Aug; 9(3):364-368. PubMed ID: 34455727 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. Porte L; Legarraga P; Vollrath V; Aguilera X; Munita JM; Araos R; Pizarro G; Vial P; Iruretagoyena M; Dittrich S; Weitzel T Int J Infect Dis; 2020 Oct; 99():328-333. PubMed ID: 32497809 [TBL] [Abstract][Full Text] [Related]
60. A prospective clinical evaluation of the diagnostic accuracy of the SARS-CoV-2 rapid antigen test using anterior nasal samples. Akashi Y; Horie M; Takeuchi Y; Togashi K; Adachi Y; Ueda A; Notake S; Nakamura K; Terada N; Kurihara Y; Kiyasu Y; Suzuki H J Infect Chemother; 2022 Jun; 28(6):780-785. PubMed ID: 35256268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]